anmelden
SPI
18.684,24
PKT
+101,75
PKT
+0,55
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SPI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 04.02.19 | Zurich Insurance buy | Merrill Lynch & Co., Inc. | |
| 04.02.19 | Roche buy | Jefferies & Company Inc. | |
| 04.02.19 | UBS buy | UBS AG | |
| 04.02.19 | UBS buy | Deutsche Bank AG | |
| 04.02.19 | Roche Reduce | HSBC | |
| 04.02.19 | Holcim Hold | HSBC | |
| 04.02.19 | Novartis Hold | Deutsche Bank AG | |
| 01.02.19 | Roche Reduce | HSBC | |
| 01.02.19 | Zurich Insurance Neutral | UBS AG | |
| 01.02.19 | Swiss Re Sell | UBS AG | |
| 01.02.19 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 01.02.19 | Novartis Underweight | Barclays Capital | |
| 01.02.19 | ams-OSRAM overweight | Barclays Capital | |
| 01.02.19 | Roche Neutral | Credit Suisse Group | |
| 01.02.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 31.01.19 | Roche Neutral | UBS AG | |
| 31.01.19 | Roche Hold | Deutsche Bank AG | |
| 31.01.19 | Novartis Neutral | Credit Suisse Group | |
| 31.01.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 31.01.19 | Roche overweight | JP Morgan Chase & Co. | |
| 31.01.19 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 31.01.19 | Roche buy | Jefferies & Company Inc. | |
| 30.01.19 | ams-OSRAM Underperform | Credit Suisse Group | |
| 30.01.19 | Novartis Hold | Deutsche Bank AG | |
| 30.01.19 | Nestlé overweight | JP Morgan Chase & Co. | |
| 30.01.19 | Roche buy | Goldman Sachs Group Inc. | |
| 30.01.19 | Novartis Neutral | UBS AG | |
| 30.01.19 | Novartis buy | Kepler Cheuvreux | |
| 30.01.19 | Roche Neutral | UBS AG | |
| 30.01.19 | Zurich Insurance Hold | Jefferies & Company Inc. | |
| 30.01.19 | Novartis buy | Jefferies & Company Inc. | |
| 30.01.19 | Nestlé buy | Goldman Sachs Group Inc. | |
| 29.01.19 | Swiss Re Outperform | Credit Suisse Group | |
| 29.01.19 | Zurich Insurance Outperform | Credit Suisse Group | |
| 29.01.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 29.01.19 | Zurich Insurance Neutral | JP Morgan Chase & Co. | |
| 29.01.19 | Givaudan Hold | Deutsche Bank AG | |
| 29.01.19 | Roche overweight | Barclays Capital | |
| 29.01.19 | UBS buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 28.01.19 | Roche Neutral | Credit Suisse Group |